<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pulmonary function testing in the evaluation of chronic dyspnea</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pulmonary function testing in the evaluation of chronic dyspnea</h1>
<div class="graphic"><div class="figure"><div class="ttl">Pulmonary function testing in the evaluation of chronic dyspnea</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33.3%"></colgroup> <tbody> <tr> <td class="subtitle1" colspan="3">Pulmonary function tests</td> </tr> <tr> <td class="subtitle2">Abnormality</td> <td class="subtitle2">Interpretation</td> <td class="subtitle2">Further testing</td> </tr> <tr class="divider_bottom"> <td>Airflow obstruction with complete reversibility following inhaled bronchodilator</td> <td>Likely asthma: Institute therapy based on severity of obstruction according to current guidelines.</td> <td>Reassess dyspnea and spirometry after treatment trial.</td> </tr> <tr> <td class="divider_bottom" rowspan="2">Airflow obstruction that is irreversible or incompletely reversible following bronchodilator</td> <td class="divider_bottom" rowspan="2">Likely COPD, especially in smokers. Chronic/severe asthma can cause airflow limitation that is incompletely reversible with bronchodilator, but may improve over time with inhaled or oral glucocorticoid therapy. Less commonly bronchiolitis or bronchiectasis.</td> <td>Reassess dyspnea and spirometry after treatment trial/pulmonary rehabilitation/smoking cessation/removal of allergen exposure.</td> </tr> <tr class="divider_bottom"> <td>Bronchiolitis should be suspected in patients with poor response to therapy for asthma/COPD or with the combination of airflow limitation and impaired gas transfer, may need HRCT to look for radiographic evidence of bronchiolitis or bronchiectasis.</td> </tr> <tr> <td class="divider_bottom" rowspan="3">Normal (expiratory) spirometry</td> <td class="divider_bottom" rowspan="3"> <p>Normal spirometry does not exclude asthma or upper airway obstruction.</p> Depending on clinical suspicion: <ul class="decimal_heading"> <li>Review inspiratory and expiratory flow volume loop for upper airway flow limitation </li> <li>Obtain bronchoprovocation challenge (eg, methacholine, mannitol, exercise) </li> <li>Obtain lung volumes, DLCO, SpO<sub>2</sub> with exercise (if not already done) </li> </ul> </td> <td>Positive bronchoprovocation: Asthma is likely cause of dyspnea. Reassess after treatment trial.</td> </tr> <tr> <td>Bronchoprovocation negative but flow volume loop has slowing on inspiratory phase suggesting possible upper airway obstruction; direct visualization needed to confirm.</td> </tr> <tr class="divider_bottom"> <td>Refer to "Lung volumes normal but DLCO reduced and/or SpO<sub>2</sub> &lt;95% or decreases by &gt;4% with exertion" below.</td> </tr> <tr> <td class="divider_bottom" rowspan="3">Reduced FVC with normal FEV<sub>1</sub>/FVC</td> <td class="divider_bottom" rowspan="3">Evaluate for restrictive process (pleural, chest wall, or neuromuscular), interstitial lung disease, or air trapping. <ul class="decimal_heading"> <li>Obtain/review lung volumes and DLCO </li> <li>Examine CXR re: pleural effusion, kyphoscoliosis, or hemidiaphragm elevation </li> </ul> </td> <td>Lung volumes (FVC and TLC) confirm restrictive pattern, DLCO normal or slightly low: Consider pleural, chest wall, and neuromuscular disease. <ul class="decimal_heading"> <li>Obtain MEP, MIP, MVV </li> <li>Review imaging </li> <li>Consider fluoroscopy for diaphragm dysfunction </li> </ul> </td> </tr> <tr> <td>Reduced DLCO and lung volumes suggest interstitial lung disease or emphysema: Consider HRCT.</td> </tr> <tr class="divider_bottom"> <td>Increased RV or FRC suggests airtrapping (eg, due to emphysema, LAM, bronchiolitis) as a cause of low FVC. HRCT can identify emphysema, cystic changes of LAM, mosaic pattern suggestive of bronchiolitis.</td> </tr> <tr class="divider_bottom"> <td>Lung volumes normal but DLCO reduced and/or SpO<sub>2</sub> &lt;95% or decreases by &gt;4% with exertion</td> <td>Possibilities include early ILD and pulmonary vascular disease: Obtain HRCT, BNP, and echocardiogram with Doppler assessment of PA pressures.</td> <td>If no ILD on HRCT and BNP and echocardiogram suggest pulmonary hypertension, may need PA catheterization.</td> </tr> <tr> <td>Normal flow volume loop, lung volumes, DLCO, ambulatory SpO<sub>2</sub>, and bronchoprovocation</td> <td>Increasing likelihood of nonrespiratory cause of dyspnea.</td> <td>Obtain/review CXR, echocardiogram. May need CPET.</td> </tr> </tbody></table></div><div class="graphic_footnotes">COPD: chronic obstructive pulmonary disease; HRCT: high resolution computed tomography; DLCO: diffusing capacity of the lungs for carbon monoxide; SpO<sub>2</sub>: pulse oxygen saturation; FVC: forced vital capacity; FEV<sub>1</sub>: forced expiratory volume in one second; CXR: chest radiograph; TLC: total lung capacity; MEP: maximal expiratory pressure; MIP: maximal inspiratory pressure; MVV: maximal voluntary ventilation; RV: right ventricular; FRC: functional residual capacity; LAM: lymphangioleiomyomatosis; ILD: interstitial lung disease; BNP: brain natriuretic peptide; PA: pulmonary artery; CPET: cardiopulmonary exercise test.</div><div id="graphicVersion">Graphic 104821 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
